Arranta Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 4

  • Investments
  • 1

Arranta Bio General Information

Description

Provider of contract development and manufacturing services intended to support the development of healthcare therapies. The company's services include process development, cGMP manufacturing of live bio-therapeutic products (LBPs), mRNA vaccine manufacturing and custom biomanufacturing, enabling clients to work on new therapies targeting diseases linked to the human microbiome that bring effective treatments for clinical and commercial supply.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • 650 Pleasant Street
  • Watertown, MA 02472
  • United States
Primary Industry
BPO/Outsource Services
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 650 Pleasant Street
  • Watertown, MA 02472
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arranta Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arranta Bio‘s full profile, request access.

Request a free trial

Arranta Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of contract development and manufacturing services intended to support the development of healthcare therapies.
BPO/Outsource Services
Watertown, MA
200 As of 2022

King of Prussia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arranta Bio Competitors (1)

One of Arranta Bio’s competitors is Center for Breakthrough Medicines, a Corporate Backed or Acquired company based in King of Prussia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Center for Breakthrough Medicines Corporate Backed or Acquired King of Prussia, PA
You’re viewing 1 of 1 competitors. Get the full list »

Arranta Bio Patents

Arranta Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260277199-A1 Methods and arrangements for inline, online, at-line, and offline process analytical technology testing (pat) boxes, fraction collectors, skids and automated sampling modules Pending 20-Oct-2025
US-20260315407-A1 Continuous process lnp formulation Pending 01-Apr-2025
WO-2026213340-A1 Continuous process lnp formulation Pending 01-Apr-2025
WO-2026192639-A1 Methods and arrangements for inline, online, at-line, and offline process analytical technology testing (pat) boxes, fraction collectors, skids and automated sampling modules Pending 14-Mar-2025
US-20260258342-A1 Methods and arrangments for process analytical technology microbial testing skid Pending 28-Feb-2025 C12M41/48
To view Arranta Bio’s complete patent history, request access »

Arranta Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arranta Bio Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Arranta Bio‘s full profile, request access.

Request a free trial

Arranta Bio Investments (1)

Arranta Bio’s most recent deal was a Buyout/LBO with Captozyme. The deal was made on 13-Nov-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Captozyme 13-Nov-2019 Buyout/LBO Biotechnology
To view Arranta Bio’s complete investments history, request access »

Arranta Bio Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Captozyme Gainesville, FL 2009

Arranta Bio FAQs

  • When was Arranta Bio founded?

    Arranta Bio was founded in 2019.

  • Where is Arranta Bio headquartered?

    Arranta Bio is headquartered in Watertown, MA.

  • What is the size of Arranta Bio?

    Arranta Bio has 200 total employees.

  • What industry is Arranta Bio in?

    Arranta Bio’s primary industry is BPO/Outsource Services.

  • Is Arranta Bio a private or public company?

    Arranta Bio is a Private company.

  • What is Arranta Bio’s current revenue?

    The current revenue for Arranta Bio is .

  • How much funding has Arranta Bio raised over time?

    Arranta Bio has raised $82M.

  • Who are Arranta Bio’s investors?

    Ampersand Capital Partners, , Kineticos Life Sciences Management, and Thermo Fisher Scientific have invested in Arranta Bio.

  • Who are Arranta Bio’s competitors?

    Center for Breakthrough Medicines is a competitor of Arranta Bio.

  • When was Arranta Bio acquired?

    Arranta Bio was acquired on 08-Apr-2022.

  • Who acquired Arranta Bio?

    Arranta Bio was acquired by Recipharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process